Literature DB >> 31129875

Treating Biliary-Enteric Anastomotic Strictures with Enteroscopy-ERCP Requires Fewer Procedures than Percutaneous Transhepatic Biliary Drains.

Hazem Hammad1, Brian C Brauer1, Maximiliano Smolkin2, Robert Ryu3, Joshua Obuch4, Raj J Shah5.   

Abstract

BACKGROUND: Biliary-enteric anastomotic strictures (AS) in long-limb surgical biliary bypass (LLBB) require percutaneous transhepatic biliary drains (PTBD), enteroscopy-assisted ERCP (E-ERCP), or surgical revision. AIM: To compare E-ERCP and PTBD for AS treatment.
METHODS: E-ERCP stricturoplasty included dilation, cautery, and stent; PTBD included balloon dilation and serial drain upsizing events.
RESULTS: From May 2008 to October 2015, 71 patients (37 M, median age 52) had E-ERCP (n = 45) or PTBD (n = 26) for AS in Roux-en-Y hepaticojejunostomy: liver transplant (n = 28), cholecystectomy injury revision (n = 21), other (n = 13) or Whipple's resection (n = 9). Median follow-up is 11 months (range 1-56) in 67 (94%) patients. Technical success, clinical improvement, and adverse events between E-ERCP and PTBD were similar (76% vs. 77%, p = 0.89; 82% vs. 85%, p = 0.80, and 6% vs. 5%, p = 0.60, respectively). However, E-ERCP had fewer post-procedural hospitalization days (0.2 ± 0.65 vs. 4.5±10, p = 0.0001), mean procedures (4.4 ± 6.3 vs. 9.5 ± 8, p = 0.006), and median months of treatment to resolve AS (1, range 1-22 vs. 7, range 3-23; p = 0.003). Two patients in PTBD group required surgery.
CONCLUSIONS: (1) Technical success and clinical improvement are seen in the majority of LLBB patients with biliary-enteric AS undergoing E-ERCP or PTBD. (2) E-ERCP is associated with fewer procedures, post-procedure hospitalization days, and months to resolve AS. When expertise is available, E-ERCP to identify and treat AS should be considered as an alternative to PTBD.

Entities:  

Keywords:  Anastomotic stricture; ERCP; Enteroscopy; PTC; Percutaneous transhepatic cholangiogram; Roux-en-Y hepaticojejunostomy

Mesh:

Year:  2019        PMID: 31129875     DOI: 10.1007/s10620-019-05670-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Roux-en-Y hepaticojejunostomy: a reappraisal of its indications and results.

Authors:  P Stefanini; M Carboni; N Patrassi; A Basoli; G de Bernardinis; P Negro
Journal:  Ann Surg       Date:  1975-02       Impact factor: 12.969

2.  Detection of biliary complications after orthotopic liver transplantation with MR cholangiography.

Authors:  P Boraschi; G Braccini; R Gigoni; G Sartoni; E Neri; F Filipponi; F Mosca; C Bartolozzi
Journal:  Magn Reson Imaging       Date:  2001-10       Impact factor: 2.546

3.  Transhepatic balloon dilation of anastomotic biliary strictures in liver transplant recipients: the significance of a patent hepatic artery.

Authors:  Wael E A Saad; Nael E A Saad; Mark G Davies; David E Lee; Nikhil C Patel; Lawrence G Sahler; Takashi Kitanosono; Talia Sasson; David L Waldman
Journal:  J Vasc Interv Radiol       Date:  2005-09       Impact factor: 3.464

Review 4.  How to prevent and manage biliary complications in living donor liver transplantation?

Authors:  Satoru Todo; Hiroyuki Furukawa; Toshiya Kamiyama
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

5.  Transhepatic dilation of anastomotic biliary strictures in liver transplant recipients with use of a combined cutting and conventional balloon protocol: technical safety and efficacy.

Authors:  Wael E A Saad; Mark G Davies; Nael E A Saad; David L Waldman; Lawrence G Sahler; David E Lee; Takashi Kitanosono; Talia Sasson; Nikhil C Patel
Journal:  J Vasc Interv Radiol       Date:  2006-05       Impact factor: 3.464

6.  Biliary anastomotic complications in 400 living related liver transplantations.

Authors:  H Egawa; Y Inomata; S Uemoto; K Asonuma; T Kiuchi; S Fujita; M Hayashi; M A Matamoros; K Itou; K Tanaka
Journal:  World J Surg       Date:  2001-10       Impact factor: 3.352

7.  Postoperative bile duct strictures: management and outcome in the 1990s.

Authors:  K D Lillemoe; G B Melton; J L Cameron; H A Pitt; K A Campbell; M A Talamini; P A Sauter; J Coleman; C J Yeo
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

8.  Bile duct injury during laparoscopic cholecystectomy: results of a national survey.

Authors:  S B Archer; D W Brown; C D Smith; G D Branum; J G Hunter
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

9.  Percutaneous management of bile duct strictures and injuries associated with laparoscopic cholecystectomy: a decade of experience.

Authors:  Sanjay Misra; Genevieve B Melton; J F Geschwind; Anthony C Venbrux; John L Cameron; Keith D Lillemoe
Journal:  J Am Coll Surg       Date:  2004-02       Impact factor: 6.113

10.  Survival in bile duct injury patients after laparoscopic cholecystectomy: a multidisciplinary approach of gastroenterologists, radiologists, and surgeons.

Authors:  Philip R de Reuver; Erik A Rauws; Marco J Bruno; Johan S Lameris; Olivier R Busch; Thomas M van Gulik; Dirk J Gouma
Journal:  Surgery       Date:  2007-07       Impact factor: 3.982

View more
  3 in total

1.  Treatment of Long-Limb Biliary-Enteric Anastomotic Strictures: ERCP, PTBD, or EUS?

Authors:  Yousuke Nakai
Journal:  Dig Dis Sci       Date:  2019-09       Impact factor: 3.199

2.  Enteroscopy‑ERCP Cannot Replace the Role of Percutaneous Transhepatic Biliary Drains in Treating Biliary‑Enteric Anastomotic Strictures.

Authors:  Yahua Li; Zhaonan Li; Juanfang Liu; Kewei Ren; Jianzhuang Ren; Xinwei Han
Journal:  Dig Dis Sci       Date:  2019-10-23       Impact factor: 3.199

3.  Factors Affecting Technical Difficulty in Balloon Enteroscopy-Assisted Endoscopic Retrograde Cholangiopancreatography in Patients with Surgically Altered Anatomy.

Authors:  Naoya Izawa; Kohei Tsuchida; Keiichi Tominaga; Koh Fukushi; Fumi Sakuma; Ken Kashima; Yasuhito Kunogi; Mimari Kanazawa; Takanao Tanaka; Kazunori Nagashima; Takahito Minaguchi; Mari Iwasaki; Akira Yamamiya; Hidehito Jinnai; Akane Yamabe; Koki Hoshi; Takeshi Sugaya; Makoto Iijima; Kenichi Goda; Atsushi Irisawa
Journal:  J Clin Med       Date:  2021-03-06       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.